BridgeBio Oncology Therapeutics, Inc.
Filer record as of 2026-09-10. Source: SEC EDGAR
- Business address
- 256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
- Category
- <br>Emerging growth company
- Cik
- 1869105
- Edgar url
- https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1869105
- Entity type
- operating
- Exchanges
- Nasdaq
- Fiscal year end
- 1231
- Former names
- Helix Acquisition Corp. II
- Name
- BridgeBio Oncology Therapeutics, Inc.
- Sic
- 2834
- Sic description
- Pharmaceutical Preparations
- State of incorporation
- DE
- Tickers
- BBOT
Filings
- BridgeBio Oncology Therapeutics, Inc. 8-K filed 2026-09-08 2026-09-08, 8-K